Frontlight ResearchEarly access
Trial site
University Cancer & Blood Center
- 5running trials
- 6closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Melanoma5 trials
- Head and neck cancer3 trials
- Metastatic breast cancer2 trials
- Colorectal cancer1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Hodgkin lymphoma1 trial
- Pancreatic cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 26 trials
- Phase 33 trials
- Phase 11 trial
- Phase 2/31 trial
- Status
- Terminated5 trials
- Recruiting3 trials
- Active, not recruiting2 trials
- Withdrawn1 trial
- Lead sponsor
- Regeneron Pharmaceuticals4 trials
- Veru Inc.2 trials
- Compass Therapeutics1 trial
- Janssen Research & Development, LLC1 trial
- Teligene US1 trial
- and 2 more
Running trials
Recruiting
Recruiting
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Melanoma2 recruiting
- Head and neck cancer1 recruiting
- Hodgkin lymphoma1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Withdrawn
Terminated
Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors
Terminated
Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast Cancer
Terminated
CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma
Terminated
Terminated
Site data: ClinicalTrials.govUpdated 18 Nov 2026